Hyperlipidemia News and Research

RSS

Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.

Exercise found to improve video game performance

Time spent playing video games is often seen as time stolen from physical activities. Research has shown that exercise has many physical and cognitive benefits.

31 Jan 2020

New genetic score is similar or more predictive than common risk factors for stroke

A group of investigators from Australia, Germany, and the UK have shown that genetic data obtained from a single blood draw or saliva sample can be used to identify individuals at a 3-fold increased risk of developing ischemic stroke, a devastating condition and one of the leading causes of disability and death world-wide.

20 Dec 2019

Heart-healthy diets can reduce risk of stroke, heart disease

Reducing dietary cholesterol by focusing on an overall heart-healthy dietary pattern that replaces saturated fats with polyunsaturated fats remains good advice for keeping artery-clogging LDL cholesterol levels healthy.

16 Dec 2019

Oversleeping puts you at risk of stroke

Stroke is one of the leading causes of mortality in the United States. A new study has found that sleeping too much, such as sleeping nine hours a day and having frequent naps may increase the risk of this cardiovascular disease.

15 Dec 2019

Study provides insight into biological effect of aging on cardiovascular disease

Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts. New basic science research finds reason to link biological aging to the development of narrowed, hardened arteries, independent of other risk factors like high cholesterol.

10 Dec 2019

Virtual cardiology follow-ups are a feasible alternative for pediatric cardiac conditions

Health provider follow-ups delivered via computer or smartphone is a feasible alternative to in-person patient follow-ups for some pediatric cardiac conditions, according to the findings of a pilot study presented at the AHA Scientific Sessions this week.

15 Nov 2019

Study defies decades-old patient eligibility guidelines for bariatric surgery

Weight-loss surgery has long been shown to improve or resolve diabetes, reduce heart attacks and stroke and produce significant weight loss, but the operation has generally been restricted by health insurers to people with severe obesity, which means about 75 to 100 pounds overweight or a body mass index (BMI) of 35 or higher.

5 Nov 2019

Discontinuing popular over-the-counter vitamin can lead of reversal of retinal swelling

In a first-of-its-kind clinical report, retina specialists at the New York Eye and Ear Infirmary of Mount Sinai have shown that severe vision loss from a self-prescribed high dose of over-the-counter niacin is linked to injury of a specific cell type in a patient's eye.

29 Oct 2019

Study investigates association between migraine diagnoses and dementia

Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship.

14 Aug 2019

Study analyzes the prevalence of antipsychotic use in youths with ADHD

Although fewer young people with ADHD are treated with antipsychotic drugs than suspected, many prescriptions for the drugs do not appear to be clinically warranted, according to a new study from psychiatry researchers at Columbia University Vagelos College of Physicians and Surgeons.

26 Jul 2019

Indigestion remedy improves survival in people with late-stage CKD

Defined as serum bicarbonate less than 22 mmol/L, metabolic acidosis is common in people with CKD stages 4-5 (eGFR < 30 ml/min/1.73 m2) and is directly related to worsening kidney function.

17 Jun 2019

Antihypertensive drug use linked with reduction in dementia risk

Various clinical trials indicate what effects can be expected from standardized intervention programs on the basis of existing evidence.

3 Jun 2019

Study shows more aggressive treatment may be needed for many patients taking statins

A new study shows more aggressive treatment may be needed for a large number of patients taking statin medications, and that treatment could help reduce cases of cardiovascular disease, the leading cause of death in the U.S.

10 May 2019

Heat-induced heart attack risk on the rise, study shows

Heart attack, or myocardial infarction, is the number one cause of death worldwide. A study published in the European Heart Journal by scientists at Helmholtz Zentrum München and colleagues from a range of other Bavarian institutions shows that the risk of suffering a heat-induced heart attack has increased significantly in recent years.

14 Mar 2019

Study finds low rates of lipid screening among women of childbearing age

Eight out of 10 women of childbearing age have never had their cholesterol levels checked, despite clear guidelines to get a first lipid blood test early in adulthood, according to research being presented at the American College of Cardiology's 68th Annual Scientific Session.

7 Mar 2019

Low-calorie meals have protective effect against some diseases, reveals research

The number of calories a person eats directly influences the performance of different cells. A group of researchers from the University of São Paulo has shown that low-calorie meals have a protective effect against some diseases.

13 Feb 2019

Study reveals impact of residual inflammatory risk on clinical outcomes after PCI

Patients who have persistently high levels of inflammation following percutaneous coronary intervention for coronary artery disease are significantly more likely to die from any cause or to have a heart attack within a year, according to a study of 7,026 patients published in the European Heart Journal.

19 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Over half of all breast cancers carry genetic defects in the p53 gene, a powerful tumor suppressor. Loss of this gene increases the risk of getting breast cancer and the resultant cancers become highly resistant to treatment.

4 Oct 2018

Study examines unnecessary medicine use in patients with advanced lung cancer

Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens.

6 Sep 2018